PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma.

The protein gene product 9.5 (PGP9.5) is a ubiquitin hydrolase that is widely expressed in neuronal tissues at all stages of neuronal differentiation and is a known neuroendocrine marker. Medullary thyroid carcinoma (MTC) arises from parafollicular cells and is reported to overexpress several mRNAs such as RET, calcitonin, and CEA. These markers are thought to be useful in determining a molecular-based diagnosis of MTC. We examined the expression levels of PGP9.5 mRNA in 80 thyroid tissues using real-time quantitative reverse transcription (RT-PCR) and found that PGP9.5 mRNA was overexpressed in all 11 MTCs examined, both hereditary and sporadic, but not in other histological tumour types. Furthermore, by RT-PCR, PGP9.5 mRNA was detected only in aspirates from three medullary carcinomas, and not in aspirates from other tumour types. These results demonstrate that, in addition to the expression of RET, calcitonin and CEA, PGP9.5 mRNA expression may contribute to the molecular-based diagnosis of MTCs.

[1]  J. Hamburger.  Diagnosis of thyroid nodules by fine needle biopsy: use and abuse. , 1994, The Journal of clinical endocrinology and metabolism.

[2]  K. Buchanan,et al.  Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid. , 1997, Journal of Endocrinology.

[3]  A. Miyauchi,et al.  Expression of oncofetal fibronectin messenger ribonucleic acid in fibroblasts in the thyroid: a possible cause of false positive results in molecular-based diagnosis of thyroid carcinomas. , 2000, The Journal of clinical endocrinology and metabolism.

[4]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[5]  T. Takano,et al.  Detection of CD44 variants in fine needle aspiration biopsies of thyroid tumor by RT-PCR. , 1997, Journal of experimental & clinical cancer research : CR.

[6]  O. Beahrs,et al.  Medullary carcinoma of the thyroid gland , 1975, Cancer.

[7]  T. Takano,et al.  Cancer-specific mRNAs in thyroid carcinomas: detection, use, and their implication in thyroid carcinogenesis. , 2002, Endocrine journal.

[8]  K D Wilkinson,et al.  The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. , 1989, Science.

[9]  A. Miyauchi,et al.  Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy. , 1999, The Journal of clinical endocrinology and metabolism.

[10]  M. Hochstrasser.  Ubiquitin-dependent protein degradation. , 1996, Annual review of genetics.

[11]  A. Miyauchi,et al.  Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. , 1999, Cancer research.

[12]  A. Nakao,et al.  PGP9.5 as a prognostic factor in pancreatic cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  S. Goodman,et al.  PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. , 1999, The American journal of pathology.

[14]  A. Miyauchi,et al.  Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies. , 1998, Cancer research.

[15]  A. Harris,et al.  The ubiquitin-proteasome pathway in cancer. , 1998, British Journal of Cancer.

[16]  Y. Edwards,et al.  PGP9.5, a ubiquitin C-terminal hydrolase; pattern of mRNA and protein expression during neural development in the mouse. , 1995, Brain research. Developmental brain research.

[17]  A. Nakao,et al.  PGP9.5 as a marker for invasive colorectal cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  J. Olerud,et al.  Protein gene product 9.5 is expressed by fibroblasts in human cutaneous wounds. , 1998, The Journal of investigative dermatology.